Selective estrogen receptor modulators (86 resultados)

hardcover. Condición: Very Good. Fast Shipping - Safe and Secure 7 days a week.

Hardcover. Condición: New. US SELLER SHIPS FROM USA.

Condición: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Condición: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Condición: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Condición: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Condición: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Condición: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Condición: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Condición: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Taschenbuch. Condición: Neu. Taxonomy of drug activity in vivo | A case study with selective estrogen receptor modulators | Gianpaolo Rando | Taschenbuch | 80 S. | Englisch | 2010 | LAP LAMBERT Academic Publishing | EAN 9783838376448 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. …

hardcover. Condición: Very Good. NOT an ex-library book. Clean copy in good condition. Quick dispatch from UK seller.

Condición: As New. Unread book in perfect condition.

Condición: New.

Condición: New.

Condición: New. pp. 388.

Condición: New.

Condición: New.

Condición: Used. pp. xviii + 358 1st Edition.

Condición: New. pp. 388 Illus.

Condición: New. In English.

Condición: New. In English.

HARDCOVER. Condición: Used; Very Good. Used; Very Good. 20-A-06 Imperial College Press 2013 Hardcover . No dust jacket as issued. SIGNED by editor on front free end page. Book Condition;Very Good . 2013. HARDCOVER.

Condición: Used. pp. xviii + 358 Illus.

Condición: New. pp. 388.

Taschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - The increasing awareness on the varied consequences of hypogonadism in distinct organs and systems has supported the notion of estrogens as systemic agents. This observation is congruent with the variety of tissues affected by - trogens when used in hormone therapy formulations on hypogonadic women. Apart from the genital tract and the breast, recognized as traditional targets for estrogens, the skeleton, the vascular tree, or the central nervous system, are good examples of territories that have demonstrated sensitivity to estrogens. This evidence has created great interest, as shown by the great amount of lit- ature that has been produced on the bene ts and risks associated with the use of estrogens. In parallel to the clinical interest, basic research has improved our kno- edge on the complexities involved in estrogen action at the molecular level. Together with effects mediated through speci c receptors, a concept that has been the mainstay of the interpretation of estrogen action for years, there is enough evidence to hold the notion of receptor-independent effects. The substantial advances in modern technology applied to research have helped in enlightening the particulars of this versatile action of estrogens. This more detailed knowledge on the sophisticated mechanism of action of estrogens has nourished the emergence of multiple hypotheses speculating with the p- sibility of manipulating estrogen action. The notion that a widely extended regulatory system of cell function, as it is the estrogen receptor machinery, might be modulated at wish has arisen as an attractive, although still elusive postulate.…

Condición: Used. pp. xviii + 358.

Condición: New. In English.

Condición: Good. Unused. Marks, scratches, dent lines, nicks & some laminate lifting to cover. Bumps/scuffs to corners & top/base of spine. Small bumps to edges of cover. Light black marks to textblock edges. Text in excellent condition.

Buch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - The increasing awareness on the varied consequences of hypogonadism in distinct organs and systems has supported the notion of estrogens as systemic agents. This observation is congruent with the variety of tissues affected by - trogens when used in hormone therapy formulations on hypogonadic women. Apart from the genital tract and the breast, recognized as traditional targets for estrogens, the skeleton, the vascular tree, or the central nervous system, are good examples of territories that have demonstrated sensitivity to estrogens. This evidence has created great interest, as shown by the great amount of lit- ature that has been produced on the bene ts and risks associated with the use of estrogens. In parallel to the clinical interest, basic research has improved our kno- edge on the complexities involved in estrogen action at the molecular level. Together with effects mediated through speci c receptors, a concept that has been the mainstay of the interpretation of estrogen action for years, there is enough evidence to hold the notion of receptor-independent effects. The substantial advances in modern technology applied to research have helped in enlightening the particulars of this versatile action of estrogens. This more detailed knowledge on the sophisticated mechanism of action of estrogens has nourished the emergence of multiple hypotheses speculating with the p- sibility of manipulating estrogen action. The notion that a widely extended regulatory system of cell function, as it is the estrogen receptor machinery, might be modulated at wish has arisen as an attractive, although still elusive postulate.…